Compile Data Set for Download or QSAR
Report error Found 17 Enz. Inhib. hit(s) with all data for entry = 50014451
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50549706(CHEMBL4744083)
Affinity DataIC50: 2.40nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576346(CHEMBL4858480)
Affinity DataIC50: 4.20nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576347(CHEMBL4849479)
Affinity DataIC50: 6.10nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576345(CHEMBL4853796)
Affinity DataIC50: 9.10nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576356(CHEMBL4854493)
Affinity DataIC50: 13nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576355(CHEMBL4872767)
Affinity DataIC50: 14nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576357(CHEMBL4850268)
Affinity DataIC50: 18nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576344(CHEMBL4851794)
Affinity DataIC50: 20nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576350(CHEMBL4877327)
Affinity DataIC50: 27nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576351(CHEMBL4866526)
Affinity DataIC50: 29nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576358(CHEMBL4869777)
Affinity DataIC50: 34nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50072084(CHEMBL3407930)
Affinity DataIC50: 34nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576349(CHEMBL4873105)
Affinity DataIC50: 37nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576352(CHEMBL4858343)
Affinity DataIC50: 39nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576354(CHEMBL4846635)
Affinity DataIC50: 62nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576353(CHEMBL4862539)
Affinity DataIC50: 84nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed
TargetKynurenine 3-monooxygenase(Human)
Sumitomo Dainippon Pharma.

Curated by ChEMBL
LigandPNGBDBM50576348(CHEMBL4850797)
Affinity DataIC50: 116nMAssay Description:Inhibition of human liver mitochondrial KMO assessed as reduction in 3-HK metabolite formation using L-kynurenine as substrate preincubated for 5 min...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/23/2022
Entry Details Article
PubMed